Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003000:Clonidine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004147:Dioxins / Q000494:pharmacology; D004837:Epinephrine / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009474:Neurons / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D012018:Reflex / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012125:Respiratory Center / Q000502:physiology*; D013997:Time Factors; D014666:Vasomotor System / Q000187:drug effects / Q000502:physiology*; D015016:Yohimbine / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D004147:Dioxins; D008781:Methyltyrosines; D010880:Piperidines; D011941:Receptors, Adrenergic; D015016:Yohimbine; D003000:Clonidine; D009638:Norepinephrine; D004837:Epinephrine